Baykara, M. Et Al. 2011. Survivin expression and its potential clinical significance in gastrointestinal stromal sarcoma. INTERNATIONAL IMMUNOPHARMACOLOGY , vol.11, no.12 , 2227-2231.

Baykara, M., Akkus, M., YILDIZ, R., IŞIK GÖNÜL, İ., DURSUN, A., Coskun, U., ... Benekli, M.(2011). Survivin expression and its potential clinical significance in gastrointestinal stromal sarcoma. INTERNATIONAL IMMUNOPHARMACOLOGY , vol.11, no.12, 2227-2231.

Baykara, Meltem Et Al. "Survivin expression and its potential clinical significance in gastrointestinal stromal sarcoma," INTERNATIONAL IMMUNOPHARMACOLOGY , vol.11, no.12, 2227-2231, 2011

Baykara, Meltem Et Al. "Survivin expression and its potential clinical significance in gastrointestinal stromal sarcoma." INTERNATIONAL IMMUNOPHARMACOLOGY , vol.11, no.12, pp.2227-2231, 2011

Baykara, M. Et Al. (2011) . "Survivin expression and its potential clinical significance in gastrointestinal stromal sarcoma." INTERNATIONAL IMMUNOPHARMACOLOGY , vol.11, no.12, pp.2227-2231.

@article{article, author={Meltem Baykara Et Al. }, title={Survivin expression and its potential clinical significance in gastrointestinal stromal sarcoma}, journal={INTERNATIONAL IMMUNOPHARMACOLOGY}, year=2011, pages={2227-2231} }